Rheos Medicines Forms Research Collaboration with CRYOSTEM

Rheos Medicines Forms Research Collaboration with CRYOSTEM

Rheos Medicines Forms Research Collaboration with CRYOSTEM to Evaluate MALT1 Targeted Therapeutics for Graft-versus-Host-Disease CAMBRIDGE, Mass., and MARSEILLE, France, October 27, 2021 – Rheos Medicines, a biopharmaceutical company bringing molecular targeting and...
New publication

New publication

Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy. Marie Tourret, Nana Talvard-Balland, Marion Lambert, Ghada Ben Youssef, Mathieu F. Chevalier, Armelle Bohineust, Thomas Yvorra, Florence Morin,...
CRYOSTEM Scientific Day – October 15, 2021 (Hybrid Event)

CRYOSTEM Scientific Day – October 15, 2021 (Hybrid Event)

CRYOSTEM Scientific Day 2021 Under the aegis of SFGM-TC Amphithéâtre Millian, Hôpital Saint-Louis, Paris. This meeting will also be held in videoconference (access codes will be shared soon). Download the program —  Call for abstracts (1 page, deadline Sep 30, 2021),...
New publication

New publication

Correlation between the recovery of certain innate immune lymphoid cells and the occurrence of GvHD after hematopoietic stem cell transplantation. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Piperoglou C, Larid...
Plenary committee 2020

Plenary committee 2020

Members of the CRYOSTEM network were all invited on Wednesday November 18 to participate in the annual meeting of the Plenary Committee. The opportunity for participants to take stock of the national cohort and discuss the ongoing valorization actions of the...